Amgen Inc. AMGN shares are trading close to its 52-week high on Wednesday after the company reported better-than-expected ...

Full-year 2026 revenue guidance was raised to a range of $38.9 billion to $39.7 billion, reflecting strong commercial ...

Amgen's Imdelltra has shown that it can significantly reduce the risk of death in patients who have extensive-stage small ...

With the first Phase 3 data expected for Amgen’s MariTide next year, analysts are looking for evidence that the GLP-1 ...

Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than ...

We recently published 8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development. Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer discussed. Cramer has recently ...

Biopharma industry veteran Jackie Elbonne, Ph.D., is retiring at the end of the year, leaving Amgen’s top quality spot to her ...

Amgen Inc.’s Q3 is near. Explore EPS growth, pipeline momentum, valuation, and dividend yield to see why it offers good ...

By Deena Beasley Nov 3 (Reuters) - Amgen on Tuesday said third-quarter sales rose 8%, led by cholesterol drug Repatha and ...

Amgen Inc. ( AMGN) announced earnings for its third quarter that Increases, from last year The company's earnings totaled $3.864 billion, or $7.08 per share. This compares with $3.216 billion, or ...

Amgen Inc. ( AMGN) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q3 2026 Earnings Conference Call. [Operator ...